Tesamorelin is a synthetic 44-amino-acid GHRH analog with a trans-3-hexenoic acid modification at the N-terminus and an extended plasma half-life, FDA-approved as Egrifta for visceral adipose tissue reduction in HIV-associated lipodystrophy
While internal cellular support begins shortly after absorption, visible or felt resultssuch as improved skin radiance or energytypically take 4 to 8 weeks of consistent daily use
Yet for a minority, the opposite can occur, and understanding the why helps guide solutions
anticholinergic agents that decrease gastric emptying) and is close to the line
Our U.S.-based labs utilize small-batch synthesis, which allows for meticulous oversight and control over the exact amino-acid sequencing
Regretfully, the use of only male rats in this study and the lack of female rats may be viewed as limitations